Genosets for APOE and CYP7A1-rs3808607 variants do not predict low-density lipoprotein cholesterol lowering upon intervention with plant sterols in a randomized, double-blind, placebo-controlled trial.
Matthew J GrangerPeter K EckItzel Vazquez-VidalMaryam ShamlooJames D HouseDylan S MacKayPublished in: The American journal of clinical nutrition (2021)
APOE and CYP7A1 genotypes did not influence the efficacy of LDL-C reductions upon dietary intervention with PS. Findings of previous post-hoc analyses could not be validated in a trial using a priori genotype-based recruitment. Obtaining adequate numbers of participants is challenging in trials using genoset-based recruitment, even for common variants.Trial Registration: Clinical Trials #NCT02765516 https://clinicaltrials.gov/ct2/show/NCT02765516.
Keyphrases
- clinical trial
- double blind
- phase iii
- study protocol
- phase ii
- randomized controlled trial
- placebo controlled
- copy number
- cognitive decline
- open label
- high fat diet
- computed tomography
- image quality
- contrast enhanced
- type diabetes
- magnetic resonance
- adipose tissue
- genome wide
- magnetic resonance imaging
- dual energy
- mild cognitive impairment
- insulin resistance
- cell wall
- skeletal muscle